估计耐药结核病新治疗方案的早期传播抑制
A Stoltz1, R R Nathavitharana2, E de Kock3
1Department of Infectious Diseases, University of Pretoria School of Medicine, Pretoria, South Africa.
The Journal of infectious diseases
|January 10, 2025
概括
在BPaL药物治疗方案中,在人对海豚模型中,在72小时内快速且完全抑制了耐药结核病 (DR-TB) 的传播. 标准治疗方案没有影响DR-TB的传播.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐药结核病 (DR-TB) 主要通过不适当治疗或未被怀疑的病例的传播传播.
- 耐药结核病治疗的最佳持续时间以阻止人与人之间的传播仍未确定.
- 正在研究新的治疗方案,以缩短治疗时间和减少传播.
研究的目的:
- 与标准治疗方案相比,评估BPaL治疗方案对DR-TB传播的影响.
- 评估短期治疗在减少DR-TB患者传染性的有效性.
- 为了利用人类对几内亚猪 (H-GP) 传播模型来评估抗结核病药物治疗方案.
主要方法:
- 使用H-GP传输模型进行了两个实验.
- 实验1:患者接受了优化的DR-TB疗法,其中包括贝达奎林 (BDQ) 和线索利德 (LZD).
- 实验2:患者接受了BPaL疗法 (BDQ,1200mg LZD和普雷托曼尼德).
- 通过将几内亚猪暴露在病房空气预处理和治疗开始72小时后来评估传染性.
- 使用结核素皮肤测试 (TST) 确定了几内亚猪感染.
主要成果:
- 在实验1中,在启动BDQ和LZD疗法72小时后,没有观察到几内亚猪感染率的显著降低 (26.7%对27.8%).
- 在实验2中,BPaL疗法证明了完全抑制传播,治疗后没有几内亚猪被感染 (0%vs44.4%).
- 两种疗法治疗后传播率的差异在统计学上是显著的 (p < 0.0001).
结论:
- 治疗BDQ和标准剂量LZD72小时并没有减少DR-TB的传播.
- BPaL疗法在治疗72小时后快速且完全抑制了DR-TB的传播.
- 这些发现表明,BPaL对DR-TB患者的传染性有着深刻和早期的影响.
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis IV
133
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K


